Therapeutic drug monitoring of vancomycin in patients with infectious complications in traumatology and orthopedics

Author:

Borisov A.M.1,Galankin T.L.2,Bozhkova S.A.1,Verbitskaya E.V.2,Kasimova A.R.1,Koroleva E.M.1

Affiliation:

1. National Medical Research Center of Traumatology and Orthopedics named after R.R. Vreden (Saint-Petersburg, Russia)

2. Pavlov First Saint-Petersburg State Medical University (Saint-Petersburg, Russia)

Abstract

Objective. The purpose of this study was to study the frequency of achievement of target values of vancomycin residual concentration (RC) and to identify the factors influencing this indicator. Materials and Methods. A retrospective observational study of vancomycin RC was performed in 471 patients who received vancomycin infusions in the department of purulent surgery of the RSRI of TO named after R.R. Vreden about capillary instillation after major orthopedic operations over the period from 01.01.2014 to 05.31.2016. Results. The target RC values on the third day of vancomycin administration reached 12.1% of patients (76.2% below target RC), after correction of the dosing regimen, the target RC was achieved in 20.3% of patients (56.9% below target RC). Multivariate analysis revealed a connection between RC and age (an increase in RC in age patients) and sex (a higher RC in women). In most cases, the prescribed doses of vancomycin corresponded to the recommended, however, the target RC levels of vancomycin were achieved only in a small proportion of patients. Conclusions. At the same time, the lowest frequency of reaching target concentrations was observed in young patients. The study proposed a multifactor model of vancomycin RC, on the basis of which it is possible to carry out the best correction of dosing taking into account the factors of age and sex.

Publisher

Interregional Association for Clinical Microbiology and Antimicrobial Chemotherapy

Subject

Pharmacology (medical)

Reference15 articles.

1. Borisov A.M., Bozhkova S.A., Konovalova M.V. Therapeutic drug monitoring of vancomycin in traumatologic and orthopedic patients. Proceedings of the 15th IACMAC international congress on antimicrobial therapy. Moscow, May 22-24, 2013. Klinicheskaja mikrobiologija i antimikrobnaja himioterapija. 2013;15(2 Suppl. 1):16.

2. Bozhkova S.A., Tihilov R.M., Krasnova M.V., Rukina A.N. Orthopedic implant-associated infection: leading pathogens, local resistance and recommendations for antibiotic therapy. Travmatologija i ortopedija Rossii. 2013;(4):5-15. Russian. DOI: 10.21823/23112905-2013-4-5-15

3. Federal guidelines for the use of medicines (formulary system). Issue XII. M.: 2011, 635-636 p. Russian.

4. Lomaestro B.M. Vancomycin dosing and monitoring 2 years after the guidelines. Expert Rev Anti Infect Ther. 2011;9(6):657-667. DOI: 10.1586/eri.11.46

5. Al-Mulhim F.A., Baragbah M.A., Sadat-Ali M., Alomran A.S., Azam M.Q. Prevalence of surgical site infection in orthopedic surgery: a 5-year analysis. Int Surg. 2014;99(3):264-268. DOI: 10.9738/INTSURG-D-13-00251.1

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3